Our businesses are actively managed by a small, efficient corporate team. We look at the core prospects for any business and beyond standard box-ticking. We think independently and are highly motivated. When a prospect has the right potential for Flex Group but needs resources we fill that gap, seizing opportunities that others overlook.

The Flex Group business aim is single and simple; to rapidly build value for our stockholders.

Bio_bigthumb

Bio-Alternative Medical Devices, or Bio-AMD, is positioned in the fast growing Point of Care (POC) medical diagnostics sector. Driven by patient need and cost savings, hand-held devices offering rapid diagnostic testing are replacing slow and expensive laboratory analysis across a range of indications. Flex Group owns 63% of BioAMD. more »
Wdx_wocu_logo_bigthumb

The WDX Organisation is an innovative financial company located in the heart of the City of London, U.K. WDX has a novel technology delivering a sophisticated financial derivative to mitigate currency risk. On May 1, 2009 Flex Group acquired 51% of WDX. Flex Group, at its option, may acquire up to a maximum of 73% of WDX's outstanding share capital. more »

News

Market data